April 2016 Analysis

Industry Trend Analysis - Collaboration Key To Arena And BI's Neuroscience Research - APR 2016

Boehringer Ingelheim and Arena's collaboration is indicative of the high demand for novel neurological drugs due to an increasing burden of disease. The deal will go a long way to support Arena's development of new compounds after its debut product, Belviq, disappointed. It also marks a shift towards a more open research model from Boehringer Ingelheim, as it attempts to overcome a loss of...

READ FULL ARTICLE